You are using an older browser version. Please use a supported version for the best MSN experience.

AbbVie buys Allergan for $63 bln

AbbVie, which produces the blockbuster drug Humira, is buying the maker of Botox, Allergan, for about $63 billion. As Fred Katayama reports, AbbVie was under pressure to diversify its lineup of drugs.
image beaconimage beaconimage beacon